Lion Point Capital »

Praxis Precision Medicines I shares owned by Lion Point Capital

Quarter-by-quarter ownership of Praxis Precision Medicines I (PRAX) shares owned by Lion Point Capital from 13F filings

Historical chart of Lion Point Capital investment in Praxis Precision Medicines I

Tip: Access up to 7 years of quarterly data

All positions including Praxis Precision Medicines I held by Lion Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Praxis Precision Medicines I by Lion Point Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $302k 5.7k 53.00

More positions owned by Lion Point Capital

Mineralys Therapeutics (MLYS)
Milestone Pharmaceuticals (MIST)
Fennec Pharmaceuticals (FENC)
Jasper Therapeutics Com New (JSPR)
Avadel Pharmaceuticals Com Shs (AVDL)
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Insmed Com Par $.01 (INSM)
Ardelyx (ARDX)
Benitec Biopharma Com New (BNTC)
Syndax Pharmaceuticals (SNDX)
Royalty Pharma Shs Class A (RPRX)
Disc Medicine (IRON)
Bridgebio Pharma (BBIO)
Geron Corporation (GERN)
Arcutis Biotherapeutics (ARQT)

View all positions for Lion Point Capital

Top funds holding Praxis Precision Medicines I

Henderson Group
Adage Capital Partners GP
BlackRock
Perceptive Advisors
Point72 Asset Management
Vanguard Group
Morgan Stanley
Cormorant Asset Management
State Street Corporation
Soleus Capital Management
Deerfield Management Company
Baker Bros. Advisors
Goldman Sachs Group
Driehaus Capital Management
Geode Capital Management

View all funds holding Praxis Precision Medicines I